Elson P - Search Results

1

Prognostic Factors and Risk Stratification in Invasive Upper Tract Urothelial Carcinoma.

Emamekhoo H, Dhillon P, Gopalakrishnan D, Elson P, Stephenson A, Magi-Galluzzi C, McKenney J, Harper H, Haber GP, Kaouk J, Lee B, Fergany A, Berglund R, Gong M, Stein R, Krishnamurthi V, Gilligan T, Ornstein M, Rini B, Garcia J, Grivas P. Emamekhoo H, et al. Among authors: elson p. Clin Genitourin Cancer. 2018 Aug;16(4):e751-e760. doi: 10.1016/j.clgc.2018.01.014. Epub 2018 Feb 6. Clin Genitourin Cancer. 2018. PMID: 29551583

2

Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma.

Elson PJ, Witte RS, Trump DL. Elson PJ, et al. Cancer Res. 1988 Dec 15;48(24 Pt 1):7310-3. Cancer Res. 1988. PMID: 3056613 Review.

3

Telomerase activity in stage II colorectal carcinoma.

Kawanishi-Tabata R, Lopez F, Fratantonio S, Kim N, Goldblum J, Tubbs R, Elson P, Lavery I, Bukowski RM, Ganapathi R, Ganapathi MK. Kawanishi-Tabata R, et al. Among authors: elson p. Cancer. 2002 Nov 1;95(9):1834-9. doi: 10.1002/cncr.10911. Cancer. 2002. PMID: 12404275 Free article.

4

Therapy and outcome of small cell carcinoma of the kidney: report of two cases and a systematic review of the literature.

Majhail NS, Elson P, Bukowski RM. Majhail NS, et al. Among authors: elson p. Cancer. 2003 Mar 15;97(6):1436-41. doi: 10.1002/cncr.11199. Cancer. 2003. PMID: 12627507 Free article. Review.

5

Prognostic factors in patients with advanced renal cell carcinoma: development of an international kidney cancer working group.

Bukowski RM, Negrier S, Elson P. Bukowski RM, et al. Among authors: elson p. Clin Cancer Res. 2004 Sep 15;10(18 Pt 2):6310S-4S. doi: 10.1158/1078-0432.CCR-050000. Clin Cancer Res. 2004. PMID: 15448023

6

Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma.

Mekhail TM, Abou-Jawde RM, Boumerhi G, Malhi S, Wood L, Elson P, Bukowski R. Mekhail TM, et al. Among authors: elson p. J Clin Oncol. 2005 Feb 1;23(4):832-41. doi: 10.1200/JCO.2005.05.179. J Clin Oncol. 2005. PMID: 15681528

7

Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma.

Suppiah R, Shaheen PE, Elson P, Misbah SA, Wood L, Motzer RJ, Negrier S, Andresen SW, Bukowski RM. Suppiah R, et al. Among authors: elson p. Cancer. 2006 Oct 15;107(8):1793-800. doi: 10.1002/cncr.22237. Cancer. 2006. PMID: 16983701 Free article.

8

Prognostic factors associated with long-term survival in previously untreated metastatic renal cell carcinoma.

Choueiri TK, Rini B, Garcia JA, Baz RC, Abou-Jawde RM, Thakkar SG, Elson P, Mekhail TM, Zhou M, Bukowski RM. Choueiri TK, et al. Among authors: elson p. Ann Oncol. 2007 Feb;18(2):249-55. doi: 10.1093/annonc/mdl371. Epub 2006 Oct 23. Ann Oncol. 2007. PMID: 17060490 Free article.

9

Phase II study of lenalidomide in patients with metastatic renal cell carcinoma.

Choueiri TK, Dreicer R, Rini BI, Elson P, Garcia JA, Thakkar SG, Baz RC, Mekhail TM, Jinks HA, Bukowski RM. Choueiri TK, et al. Among authors: elson p. Cancer. 2006 Dec 1;107(11):2609-16. doi: 10.1002/cncr.22290. Cancer. 2006. PMID: 17075879 Free article. Clinical Trial.

10

Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy.

Choueiri TK, Garcia JA, Elson P, Khasawneh M, Usman S, Golshayan AR, Baz RC, Wood L, Rini BI, Bukowski RM. Choueiri TK, et al. Among authors: elson p. Cancer. 2007 Aug 1;110(3):543-50. doi: 10.1002/cncr.22827. Cancer. 2007. PMID: 17577222 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

226 results

Search Page

Filters